Comparative assessment of plaque removal and motivation between a manual toothbrush and an interactive power toothbrush in adolescents with fixed orthodontic appliances: A single-center, examiner-blind randomized controlled trial.


Journal

American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics
ISSN: 1097-6752
Titre abrégé: Am J Orthod Dentofacial Orthop
Pays: United States
ID NLM: 8610224

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 01 03 2018
revised: 01 12 2018
accepted: 01 12 2018
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 16 4 2019
Statut: ppublish

Résumé

The objective of this 2-arm parallel trial was to determine the plaque removal efficacy (main outcome) and the motivation assessment (secondary outcome) comparing a manual versus an interactive power toothbrush in orthodontic patients. Sixty adolescents with fixed orthodontic appliances in both arches were randomized in a 1:1 ratio in this parallel, randomized, examiner-blind controlled clinical trial. Eligibility criteria included at least 16 natural teeth, 1-6 "focus care areas," plaque score of ≥1.75, no severe caries, gingivitis and periodontitis, no dental prophylaxis, no smoking, no antibiotics, and no chlorhexidine mouth rinse. Subjects were to brush unsupervised with either an interactive power toothbrush (Oral-B Professional Care 6000, D36/EB20) with Bluetooth technology or a regular manual toothbrush (Oral-B Indicator 35 soft). Focus care areas were each brushed for 10 additional seconds. Plaque removal was assessed with the use of the Turesky Modification of the Quigley-Hein Plaque Index (TMQHPI) to determine change from baseline at 2 and 6 weeks. Supervised brushing at screening and post-treatment visits recorded actual brushing times. Subject-reported motivational aspects were recorded at screening and week 6. Fifty-nine subjects aged 13-17 years completed the study. The interactive power toothbrush provided significantly (P <0.001) greater plaque reduction versus the manual toothbrush at 2 and 6 weeks according to the whole-mouth TMQHPI. The treatment difference in adjusted mean plaque change from baseline was 0.777 (95% CI 0.614-0.940) at week 2 and 0.834 (0.686-0.981) at week 6. Mean reductions in the number of focus care areas were also significantly greater (P <0.001) in the power brush group at weeks 2 and 6. Brushing times increased significantly at weeks 2 and 6 (P ≤0.013) versus baseline in the interactive power brush group only. Subject-reported motivation was significantly increased in the interactive power brush group at week 6 versus screening (P ≤0.005). An interactive power toothbrush generated increased brushing times and significantly greater plaque removal versus a manual brush.

Identifiants

pubmed: 30935601
pii: S0889-5406(19)30001-0
doi: 10.1016/j.ajodo.2018.12.013
pii:
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-472

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Christina Erbe (C)

Department of Orthodontics and Dentofacial Orthopedics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany. Electronic address: erbe@uni-mainz.de.

Violetta Klees (V)

Department of Orthodontics and Dentofacial Orthopedics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Fabienne Braunbeck (F)

Department of Orthodontics and Dentofacial Orthopedics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Priscila Ferrari-Peron (P)

Department of Orthodontics and Dentofacial Orthopedics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Renzo A Ccahuana-Vasquez (RA)

Research and Development, Procter & Gamble Company, Kronberg, Germany.

Hans Timm (H)

Research and Development, Procter & Gamble Company, Kronberg, Germany.

Julie Grender (J)

Research and Development, Procter & Gamble Company, Mason, Ohio.

Pamela Cunningham (P)

Research and Development, Procter & Gamble Company, Mason, Ohio.

Ralf Adam (R)

Research and Development, Procter & Gamble Company, Kronberg, Germany.

Heinrich Wehrbein (H)

Department of Orthodontics and Dentofacial Orthopedics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH